Showing 9991-10000 of 19421 results for "".
- Understanding the Long-Term Mental Health Implications of COVID-19 on Athleteshttps://reachmd.com/news/understanding-the-long-term-mental-health-implications-of-covid-19-on-athletes/2475896/Understanding the long-term mental health implications of COVID-19 on athletes can enhance treatment strategies and improve psychological resilience. When lockdowns closed training centers and canceled competitions overnight, high-performance athletes faced a profound loss of routine
- Enhancing Adenocarcinoma Diagnosis with LAMP1-Targeted PET Imaginghttps://reachmd.com/news/enhancing-adenocarcinoma-diagnosis-with-lamp1-targeted-pet-imaging/2475897/Emerging data on the lysosomal-associated membrane protein 1 (LAMP1) are redefining the sensitivity and specificity of PET imaging in adenocarcinoma diagnostics, offering oncologists and radiologists a more precise molecular window into tumor biology. Accurate diagnosis and staging o
- Evolving Neuroblastoma Imaging: Enhanced Precision with [18F]MFBG PET/CThttps://reachmd.com/news/evolving-neuroblastoma-imaging-enhanced-precision-with-18fmfbg-petct/2475900/Emerging real-world data underscores how advanced tumor imaging modalities such as [18F]MFBG PET/CT are redefining diagnostic precision in pediatric oncology, outpacing somatostatin receptor PET in sensitivity for neuroblastoma detection. Imaging stands as a cornerstone in neuroblast
- AI's Evolving Role in Radiology: Balancing Innovation with Cautionhttps://reachmd.com/news/ais-evolving-role-in-radiology-balancing-innovation-with-caution/2475863/In radiology departments worldwide, while artificial intelligence algorithms enhance diagnostic precision and efficiency, challenges such as data privacy and model biases remain significant barriers. The proliferation of AI-driven solutions has led to 173 products entering clinical r
- Gene Therapy's Promise in Inherited Retinal Diseaseshttps://reachmd.com/news/gene-therapys-promise-in-inherited-retinal-diseases/2475876/Gene therapy for inherited retinal diseases (IRDs) is reaching a tipping point where targeted genetic corrections could shift decades-old paradigms of vision loss management. Inherited retinal diseases affect approximately one in 2,000 individuals and pose a formidable clinical chall
- Overcoming Therapeutic Inertia in Metastatic Castration-Resistant Prostate Cancer with Radium-223https://reachmd.com/news/overcoming-therapeutic-inertia-in-metastatic-castration-resistant-prostate-cancer-with-radium-223/2475881/Overcoming therapeutic inertia in metastatic castration-resistant prostate cancer demands a paradigm shift, and consideration of early integration of Radium-223 into the treatment algorithm can be informed by
- Integrating Oncology and Dermatology: Addressing ICI-Induced Psoriasis Riskhttps://reachmd.com/news/integrating-oncology-and-dermatology-addressing-ici-induced-psoriasis-risk/2475860/The integration of oncology and dermatology is increasingly important as immune checkpoint inhibitors (ICIs) transform cancer care and elevate psoriasis risk among survivors. Clinicians now face an unexpected challenge: the introduction of
- Innovative Disease Modeling in Alzheimer’s: A New Frontier in Diagnosis and Treatmenthttps://reachmd.com/news/innovative-disease-modeling-in-alzheimers-a-new-frontier-in-diagnosis-and-treatment/2475864/Alzheimer’s disease modeling is unlocking unprecedented insight into tau protein propagation and genetic vulnerability, offering a transformative lens for diagnosis and therapy. Neurologists face a pressing challenge: the uneven spread of neurofibrillary tangles and tau protein acros
- Emerging Innovations in Neonatal Care: Transforming Outcomes for Preterm Infantshttps://reachmd.com/news/emerging-innovations-in-neonatal-care-transforming-outcomes-for-preterm-infants/2475868/Emerging Innovations in Neonatal Care: Transforming Outcomes for Preterm Infants The incidence of respiratory distress syndrome in preterm infants varies significantly with gestational age, for example, 98% at 24 weeks, which has led to the rapid adoption of non-invasive hi
- Unlocking the Potential of Autoantibodies in Cancer Immunotherapyhttps://reachmd.com/news/unlocking-the-potential-of-autoantibodies-in-cancer-immunotherapy/2475879/Advancements in personalized medicine and immunotherapy are opening new possibilities in cancer treatment. However, predicting which patients will respond remains challenging. Autoantibodies have become important indicators of patient response, and ensuring that engineered immune cells rema